Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5025-5035

  Helmrich, Uta ^a   Di Maggio, Nunzia ^a   Güven, Sinan ^a   Groppa, Elena ^a   Melly, Ludovic ^a   Largo, Rene D ^a   Heberer, Michael ^a   Martin, Ivan ^a   Scherberich, Arnaud ^a   Banfi, Andrea ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angiogenesis; Bone tissue engineering; Mesenchymal stem cell; Osteoclast; Silicate substituted apatite; VEGF

Indexed keywords

ANGIOGENESIS; BONE TISSUE ENGINEERING; MESENCHYMAL STEM CELL; OSTEOCLAST; VEGF;

APATITE; CELL CULTURE; CONDUCTIVE MATERIALS; GRAFTS; PHYSIOLOGY; SILICATES; TISSUE; TISSUE ENGINEERING;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; SILICATE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BONE GRAFT; CELL BASED GENE THERAPY; CELL SELECTION; CONDUCTANCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE EXPRESSION; TISSUE ENGINEERING; VASCULARIZATION;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MATRIX; BONE RESORPTION; CATHEPSIN K; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; ISOENZYMES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCLASTS; OSTEOGENESIS; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84877044029     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.040     Document Type: Article

References (49)

1. Marolt D., Knezevic M., Novakovic G.V. Bone tissue engineering with human stem cells. Stem Cell Res Ther 2010, 1:10.
2. Kneser U., Stangenberg L., Ohnolz J., Buettner O., Stern-Straeter J., Mobest A., et al. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. JCell Mol Med 2006, 10:695-707.
3. Scheufler O., Schaefer D.J., Jaquiery C., Braccini A., Wendt D.J., Gasser J.A., et al. Spatial and temporal patterns of bone formation in ectopically pre-fabricated, autologous cell-based engineered bone flaps in rabbits. JCell Mol Med 2008, 12:1238-1249.
4. Gerber H.P., Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 2000, 10:223-228.
5. Brandi M.L., Collin-Osdoby P. Vascular biology and the skeleton. JBone Miner Res 2006, 21:183-192.
6. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., Nagel D., Riggs B.L., Khosla S. Circulating osteoblast-lineage cells in humans. NEngl J Med 2005, 352:1959-1966.
7. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
8. Kneser U., Schaefer D.J., Polykandriotis E., Horch R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. JCell Mol Med 2006, 10:7-19.
9. Scherberich A., Muller A.M., Schafer D.J., Banfi A., Martin I. Adipose tissue-derived progenitors for engineering osteogenic and vasculogenic grafts. JCell Physiol 2010, 225:348-353.
10. Santos M.I., Reis R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010, 10:12-27.
11. Kanczler J.M., Ginty P.J., White L., Clarke N.M.P., Howdle S.M., Shakesheff K.M., et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010, 31:1242-1250.
12. Koob S., Torio-Padron N., Stark G.B., Hannig C., Stankovic Z., Finkenzeller G. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A 2011, 17:311-321.
13. Buschmann J., Welti M., Hemmi S., Neuenschwander P., Baltes C., Giovanoli P., et al. Three-dimensional co-cultures of osteoblasts and endothelial cells in DegraPol foam: histological and high-field magnetic resonance imaging analyses of pre-engineered capillary networks in bone grafts. Tissue Eng Part A 2011, 17:291-299.
14. Gueven S., Mehrkens A., Saxer F., Schaefer D.J., Martinetti R., Martin I., et al. Engineering of large osteogenic grafts with rapid engraftment capacity using mesenchymal and endothelial progenitors from human adipose tissue. Biomaterials 2011, 32:5801-5809.
15. Yla-Herttuala S., Rissanen T.T., Vajanto I., Hartikainen J. Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine. JAm Coll Cardiol 2007, 49:1015-1026.
16. Ozawa C.R., Banfi A., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. JClin Invest 2004, 113:516-527.
17. Dor Y., Djonov V., Abramovitch R., Itin A., Fishman G.I., Carmeliet P., et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. Embo J 2002, 21:1939-1947.
18. Tafuro S., Ayuso E., Zacchigna S., Zentilin L., Moimas S., Dore F., et al. Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression. Cardiovasc Res 2009, 83:663-671.
19. Rissanen T.T., Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 2007, 15:1233-1247.
20. Galotto M., Berisso G., Delfino L., Podesta M., Ottaggio L., Dallorso S., et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999, 27:1460-1466.
21. Helmrich U., Marsano A., Melly L., Wolff T., Christ L., Heberer M., et al. Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue Eng Part C Methods 2012, 18:283-292.
22. Wolff T., Mujagic E., Gianni-Barrera R., Fueglistaler P., Helmrich U., Misteli H., et al. FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia. JCell Mol Med 2012, 16:107-117.
23. Mehrkens A., Saxer F., Mueller A.M., Gueven S., Schaefer D.J., Heberer M., et al. Successful one-step engineering of osteogenic grafts with cells freshly isolated from human adipose tissue. Br J Surg 2010, 97:S38.
24. Scherberich A., Galli R., Jaquiery C., Farhadi J., Martin I. Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells 2007, 25:1823-1829.
25. Kusser K.L., Randall T.D. Simultaneous detection of EGFP and cell surface markers by fluorescence microscopy in lymphoid tissues. JHistochem Cytochem 2003, 51:5-14.
26. Mueller A.M., Davenport M., Verrier S., Droeser R., Alini M., Bocelli-Tyndall C., et al. Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 2009, 15:869-875.
27. Martin I., Mastrogiacomo M., De Leo G., Muraglia A., Beltrame F., Cancedda R., et al. Fluorescence microscopy imaging of bone for automated histomorphometry. Tissue Eng 2002, 8:847-852.
28. Kasten P., Vogel J., Luginbuhl R., Niemeyer P., Tonak M., Lorenz H., et al. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 2005, 26:5879-5889.
29. Chai Y.C., Roberts S.J., Desmet E., Kerckhofs G., van Gastel N., Geris L., et al. Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials 2012, 33:3127-3142.
30. Boiret N., Rapatel C., Veyrat-Masson R., Guillouard L., Guerin J.J., Pigeon P., et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 2005, 33:219-225.
31. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
32. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
33. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of exvivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000, 28:707-715.
34. Crisan M., Corselli M., Chen W.C., Peault B. Perivascular cells for regenerative medicine. JCell Mol Med 2012, 16:2851-2860.
35. Feng X., McDonald J.M. Disorders of bone remodeling. Annu Rev Pathol 2011, 6:121-145.
36. Bianco P., Robey P.G., Saggio I., Riminucci M. "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 2010, 21:1057-1066.
37. DiGirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999, 107:275-281.
38. Hodgkinson C.P., Gomez J.A., Mirotsou M., Dzau V.J. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010, 21:1513-1526.
39. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., et al. VEGF is required for growth and survival in neonatal mice. Development 1999, 126:1149-1159.
40. Zelzer E., Olsen B.R. The genetic basis for skeletal diseases. Nature 2003, 423:343-348.
41. Maes C., Goossens S., Bartunkova S., Drogat B., Coenegrachts L., Stockmans I., et al. Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. Embo J 2010, 29:424-441.
42. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
43. Hiltunen M.O., Ruuskanen M., Huuskonen J., Mahonen A.J., Ahonen M., Rutanen J., et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation invivo. FASEB J 2003, 17:1147-1149.
44. Casap N., Venezia N.B., Wilensky A., Samuni Y. VEGF facilitates periosteal distraction-induced osteogenesis in rabbits: a micro-computerized tomography study. Tissue Eng Part A 2008, 14:247-253.
45. Zhang C., Wang K.Z., Qiang H., Tang Y.L., Li Q.A., Li M.A., et al. Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector invitro and invivo. Acta Pharmacol Sin 2010, 31:821-830.
46. Schonmeyr B.H., Soares M., Avraham T., Clavin N.W., Gewalli F., Mehrara B.J. Vascular endothelial growth factor inhibits bone morphogenetic protein 2 expression in rat mesenchymal stem cells. Tissue Eng Part A 2010, 16:653-662.
47. Niida S., Kaku M., Amano H., Yoshida H., Kataoka H., Nishikawa S., et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. JExp Med 1999, 190:293-298.
48. Yang Q.L., McHugh K.P., Patntirapong S., Gu X.S., Wunderlich L., Hauschka P.V. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta(3)-integrin. Matrix Biol 2008, 27:589-599.
49. Lau R., Guo X. Areview on current osteoporosis research: with special focus on disuse bone loss. JOsteopor 2011, 2011:293808.